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Abstract
Background: Delirium affects 25% of older inpatients and is associated with long-term cognitive impairment and
future dementia. However, no population studies have systematically ascertained cognitive function before, cognitive
deficits during, and cognitive impairment after delirium. Therefore, there is a need to address the following question:
does delirium, and its features (including severity, duration, and presumed aetiologies), predict long-term cognitive
impairment, independent of cognitive impairment at baseline?
Methods: The Delirium and Population Health Informatics Cohort (DELPHIC) study is an observational population-
based cohort study based in the London Borough of Camden. It is recruiting 2000 individuals aged ≥70 years and
prospectively following them for two years, including daily ascertainment of all inpatient episodes for delirium. Daily
inpatient assessments include the Memorial Delirium Assessment Scale, the Observational Scale for Level of Arousal,
and the Hierarchical Assessment of Balance and Mobility. Data on delirium aetiology is also collected. The primary
outcome is the change in the modified Telephone Interview for Cognitive Status at two years.
Discussion: DELPHIC is the first population sample to assess older persons before, during and after hospitalisation. The
cumulative incidence of delirium in the general population aged ≥70 will be described. DELPHIC offers the opportunity
to quantify the impact of delirium on cognitive and functional outcomes. Overall, DELPHIC will provide a real-time
public health observatory whereby information from primary, secondary, intermediate and social care can be
integrated to understand how acute illness is linked to health and social care outcomes.
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Background
Delirium is a severe neuropsychiatric syndrome mainly
precipitated by acute illness, affecting at least 1 in 8
inpatients in industrialised countries. [1–3] Symptoms
include acute onset of inattention, other cognitive defi-
cits, altered level of consciousness, and psychosis. [4]
Delirium has multiple adverse consequences, including
higher mortality, longer hospital stay, and increased
institutionalisation. [5–7] It is also highly distressing for
patients, carers and staff. [8]
A range of studies have demonstrated that delirium is
associated with future long-term cognitive impairment.
[9–15] However, these have major methodological
limitations, either:
(i) Delirium outcomes have been measured without pre-
morbid baseline cognitive assessments, i.e. observed
cognitive impairment at follow-up is confounded by
undiagnosed pre-existing cognitive impairment (Fig. 1,
top panel); [13, 16] or
(ii)Delirium has been retrospectively ascertained, so
detailed information on the features any delirium is
lacking (Fig. 1, middle panel). [9–12, 14, 15]
Thus, a critical gap is that no study has involved all
three of the essential elements of (a) determining base-
line cognitive function, then (b) ascertaining delirium
prospectively, and then (c) assessing delirium’s impact
on future long-term cognitive impairment. This is the
key approach of the current study (Fig. 1, bottom panel).
Prospective ascertainment of delirium is important
for several reasons. First, it is less subject to recall
bias, which is common in the context of residual cog-
nitive impairment. Second, prospective ascertainment
allows for detailed assessment of the features of
delirium. This is crucial because there are wide
variations in the features of delirium, including
severity, duration, and aetiology. [17] Such variations
likely influence the risk of long-term cognitive impair-
ment because delirium features affect other outcomes.
[18–21] Finally, a focus on delirium would make
possible the differentiation between its specific impact
on cognitive outcomes, as opposed to the cognitive
decline described in association with acute hospita-
lisation in general. [22–24]
To advance our understanding of the relationship
between delirium and long-term cognitive impair-
ment, we need to address the following question: does
delirium, and its features (including severity, duration,
and presumed aetiologies), predict long-term cognitive
impairment, independent of cognitive impairment at
baseline?
A definitive understanding of the natural history of de-
lirium on risk of long-term cognitive impairment would
have implications for identification and follow-up of pa-
tients at high risk of dementia, targeting acute treatment
strategies, directing further research on mechanisms,
and providing prognostic information to patients and
carers.
Methods
Aim To determine the impact of delirium, and its
features, on the risk of long-term cognitive impairment
in a population sample.
Objective 1 Recruit a population sample, the Delirium
and Population Health Informatics Cohort (DELPHIC)
(n = 2000).
Objective 2 Undertake a minimum of two community-
based cognitive assessments, at baseline and two years.
Fig. 1 Studies examining delirium in relation to cognitive decline. Top panel: Hospitalised cohorts lack prospective measures of pre-morbid cogni-
tion. Middle panel: Population cohorts characterise cognition in community, retrospectively ascertaining delirium. Lower panel: A cohort prospect-
ively tracking cognition before, during and after acute illness
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Objective 3 Ascertain cumulative incidence of delirium
(across community and hospital settings).
Objective 4 Quantify impact of delirium on change in
long-term cognitive function.
Hypothesis Incident delirium is associated with changes
in global cognitive scores (pre-delirium compared to
scores at two-year follow-up).
Design
This is a prospective study of delirium and its features in
relation to long-term cognitive impairment, recruiting a
population sample and assessing cognition before,
during and after delirium. Although DELPHIC is the sci-
entific name for this study, recruitment will be known
locally under the name: Long-term Information and
Knowledge for Ageing (LINKAGE) Camden (www.link-
age-camden.com).
Population setting and sample
The sampling frame is geographically defined by the
London Borough of Camden. Camden has 230,000 resi-
dents, 16,500 (7%) of whom are aged ≥70. It is one of
the most socio-economically varied areas of Europe.
There is wide ethnic diversity; 16% of the population
age ≥ 65 are non-White British according to the 2011
census.
All health care (primary and secondary) is commis-
sioned by a single Clinical Commissioning Group (CCG)
comprising 39 GP surgeries. The CCG is also co-
terminus with provision of community rehabilitation
(district nurses, physiotherapy, occupational therapy)
and all community mental health services are provided
by Camden and Islington NHS Foundation Trust. Social
services and public health are provided by the local au-
thority directly. Camden is served by two acute hospi-
tals, University College Hospital (UCH) and the Royal
Free Hospital (RFH). These are the main sites for clinical
ascertainment of delirium. Together, this represents the
opportunity to determine and integrate the entire health
and social care usage of participants over the follow-up
period.
Eligibility
Inclusion criteria: Resident in Camden, registered with
a Camden GP, age ≥ 70 years.
Exclusion criteria: Severe hearing impairment or apha-
sia, unable to speak English sufficiently to undertake any
cognitive assessment, terminal phase of illness.
Participant characteristics
Participants are recruited from the 39 general prac-
tices in sequence, initially targeting the larger prac-
tices and purposively including a wide socio-economic
distribution. Two care homes are also involved, with
the aim of including a representative proportion of
the Camden population in residential and nursing
care (approximately 5% of sample). Patients previously
under care of University College and Royal Free
Hospitals are also approached. Patients known to
Camden Memory Service are invited (Fig. 2).
Through approaching participants from GP registers
(generally healthy), those known to hospital services
(enriched for comorbidity) and memory clinics (enriched
for dementia) in a 8:1:1 ratio, the target sample is ex-
pected to match the age structure of the 2011 census, as
well as have the expected distribution of cognitive func-
tion in the population using data from the Cognitive
Function and Ageing Study II. [25]
Consent
Consent is obtained in line with the principles of Good
Clinical Practice. At the start of the study, participants
will also be asked to consider their wish to remain in the
study in the event that they lose capacity during the
study period.
This study will involve participants who lack capacity
because it is specifically about cognitive impairment and
its acute and chronic determinants. At this project’s
heart is the recognition that older adults with cognitive
impairment have high health and social care needs, but
with little research that understands the impact of hav-
ing cognitive impairment as individuals move between
primary, secondary and intermediate care. This research
is designed to investigate directly the needs of adults
with cognitive impairment, including those unable to
give consent for themselves. To not include such partici-
pants introduces bias into the research and leaves clini-
cians and policy makers with no research data to
improve care for older patients unable to give consent
and invalidate the study almost entirely. [26]
For those lacking capacity, a consultee will be
sought. Consultees will be routinely sought for all
participants, including those with capacity who give
consent for this. Where necessary, this may include
the GP acting as a professional consultee in line with
Section 32 of the Mental Capacity Act. In many
cases, consultees will provide important collateral in-
formation and their continued involvement will be
encouraged. Capacity can fluctuate during delirium
and dementia. Where an event occurs that is part of
the study (e.g. hospitalisation), consultees will be
sought if the participant is unable to give continued
consent as appropriate. Thereby, it is intended that
for those individuals who lose capacity at any stage
the research will continue to be able to participate
under the terms of the Mental Capacity Act 2005.
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Data to be collected
All participants undergo a baseline assessment, repeated
two years later. Data collection started in March 2017
and end of the follow-up period will be in March 2020.
Those admitted to hospital will be seen throughout their
admission, usually daily. Participants discharged from
hospital, and those deemed to be at high risk for
delirium will be contacted every two months by tele-
phone in order to estimate incidence of delirium in the
community using the Informant Assessment of Geriatric
Delirium [27] and quantify trajectories of recovery after
delirium (Fig. 3). The data acquired in each setting are
summarised in Table 1.
Community assessments
These are mainly undertaken by telephone, though some
participants are seen at home or in the Bloomsbury
Centre for Clinical Phenotyping. The whole sample is
assessed at baseline and two years later (primary out-
come measure). In addition, a 12.5% subsample (n = 250)
of the most cognitively impaired (highest-risk for
Fig. 2 Study flow diagram showing recruitment sources, follow-up and expected attrition over two years
Fig. 3 Schematic showing telephone contacts and cognitive testing in four examples, depending on baseline risk for delirium. Both the number
of contacts and cognitive assessments increase in the event of hospitalisation
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delirium) is being proactively monitored by the research
team (Fig. 3).
The baseline contact comprises:
– Consent for involvement in DELPHIC, specifically
including: hospital assessments in the event of acute
illness (particularly if capacity is impaired through
delirium or dementia at subsequent contacts);
record linkage of electronic health data in primary
and secondary care
– If capacity to consent is impaired, a consultee
declaration will be sought, in line with NHS Health
Research Authority guidance
– Nomination of consultees
– Administration of the Modified Telephone Interview
for Cognitive Status (TICS-m), [28, 29] plus verbal
fluency and other memory tests from the
Addenbrooke’s Cognitive Examination III
– Other measures of health and wellbeing, including:
general health, co-morbidities, medications, health
behaviours, hearing, vision, quality of life, continence,
falls, depression, personal and instrumental activities
of daily living (Table 1)
TICS-m is a widely-used, validated test which takes
10 min to administer over the telephone or in person.
[30] Cognitive domains measured include: orientation,
concentration, delayed recall, language, praxis, calcula-
tion, verbal comprehension. It is scored out of 50 points
and has a normal distribution in population samples of
older persons. [31] While severe hearing impairment
would preclude assessment with TICS-m, it is possible
to test individuals with severe visual and/or motor
impairments.
Proactive telephone contact for highest risk
Age and baseline cognitive impairment are the strongest
risk factors for delirium. A subsample of the 12.5% most
cognitively impaired (n = 250) (Table 2) are selected for
enhanced delirium surveillance, before and after any
Table 1 Summary of assessments
Baseline and follow-up Hospital
Domain Instrument Domain Instrument
Sociodemographic Delirium severity MDAS
General health From NSHD Arousal OSLA
Co-morbidities Inattention DelApp
Medications Balance and mobility HABAM
Life Space Assessment PADL Barthel
Quality of life EQ5D-5 L Frailty CFS
Vision and hearing From NSHD Laboratory values
Continence ICIQ-SF
Constipation Pain VAS
Leisure time physical activity NSHD Grip strength Nottingham
electronic dynamometer
Dental health
Podiatric health
Falls From CC75C Co-morbidities CIRS-G
Nutrition MNA Medications Anti-cholinergic burden scale
Delirium From NSHD Acute physiology APACHE-II, NEWS
Depression GDS-4, CES-D8
Subjective memory complaint From NSHD
Cognition TICS-m; verbal fluency;
selected parts of ACE-III
PADL Barthel score
IADL NEADS
NSHD MRC National Survey for Health and Development (https://doi.org/10.5522/NSHD/Q103); EQ5D-5 L EuroQol (5 domain); ICIQ-SF International Consultation on
Incontinence Questionnaire - Short Form; CC75C Cambridge City over-75 s Cohort; MNA Mini-Nutritional Assessment; GDS Geriatric Depression Scale; CES-D Center
for Epidemiological Studies – Depression; TICS-m modified Telephone Interview for Cognitive Assessment; ACE-III Addenbrooke’s Cognitive Examination III; PADL
Personal Activities of Daily Living; IADL Instrumental Activities of Daily Living; NEADS Nottingham Extended Activities of Daily living scale; MDAS Memorial Delirium
Assessment Scale; OSLA Observational Scale for Level of Arousal; HABAM Hierarchical Assessment of Balance and Mobility; CFS Clinical Frailty Scale; CIRS-G Cumula-
tive Illness Rating Scale for Geriatrics; Acute Physiology and Chronic Health Evaluation-II; NEWS National Early Warning Score
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hospitalisations (Fig. 3). This strategy has previously
been used for ascertaining other acute events in popula-
tion samples, e.g. falls. [32, 33] This allows for the most
complete understanding of how delirium develops and
patterns of recovery across healthcare settings, thereby
challenging the assumption that most delirium presents
to acute hospitals.
The research team undertake telephone contacts each
day (Monday-Friday), covering the subsample of 250
participants and/or their nominated trusted advisors
(consultees) every two months (Fig. 3). Each contact has
the following purposes:
– Assess any new health problem (every two months).
– Assess any delirium symptoms using the validated
Informant Interview for Geriatric Delirium (I-AGeD
[27]). This provides key information on community
delirium both before hospitalisation and tracks
recovery after hospital (every two months).
– Repeated TICS-m in participants after discharge
(every four months) (Fig. 3).
Hospital assessments
Admissions lists are screened Monday-Friday, identifying
participants who have been admitted (emergency and
elective). Specific audit data from Camden practices,
along with reports from NHS Digital, indicate that the
admission rate in this age group is up to 20/1000/month.
This amounts to 1000 events over the two year study
period, with the highest-risk being admitted recurrently.
Identified admissions are assessed for delirium. Key
definitions are given in Table 3. Data recorded includes
information collected through usual clinical care:
– Demographic: age, sex, education, place of residence,
co-resident support
– Clinical: admission details, physiological
measurements (National Early Warning Scores
(NEWS)), illness severity scores (Acute Physiology
and Chronic Health Evaluation (APACHE) II (minus
arterial blood gas)), medications.
– Delirium: general cognition (TICS-m), MDAS,
arousal, attention (including the DelApp [34]),
functional balance and mobility, aetiological factors.
Participants admitted to UCH or RFH are seen
every weekday. Relevant clinical data from out-of-
hours (including weekends and participants dis-
charged before assessment) maximise ascertainment
using validated method for detecting delirium from
medical notes and interviews with ward staff and
family. [35] Hospitalised participants will be followed
up at St Pancras Hospital if they are discharged to
bed-based rehabilitation. Participants at St Pancras
will be seen a minimum of twice a week.
After hospitalisation, participants (and/or proxies) will
continue to be proactively contacted as described above.
There will be up to five additional occasions for admin-
istering TICS-m, adding longitudinal information on tra-
jectories to recovery or persistent delirium (Fig. 3).
Delirium ascertainment is supervised by DD, with dif-
ficult cases used for ongoing training and knowledge
sharing. Complex cases are adjudicated on a monthly
basis with input from specialist old age liaison psychiatry
(ES). The final delirium variables (incidence, duration,
severity, aetiology) will be derived by an expert consen-
sus panel, blinded to outcome data. All available in-
patient assessments, telephone contacts, electronic
hospital and GP records collected for data linkage will
be used.
Table 2 Age structure of DELPHIC in relation to dementia prevalence, hospital presentation rate and sample for proactive contact
Age (years) Camden DELPHIC cohort
(N)a
Prevalent dementia
N (%)
Incident dementia
N (%/year)
Expected mortality
(annual)
% Proactive contact High-risk (N)
70–74 5631 676 34% 18 2.7% 5 0.7 2% 14 5% 33
75–79 4442 533 27% 30 5.7% 9 1.6 3.5% 19 10% 53
80–84 3455 414 21% 41 9.9% 14 3.3 6.5% 27 15% 62
85–89 2048 246 12% 38 16% 12 4.8 15% 37 20% 49
≥90 1095 131 7% 35 27% 6 4.8 15% 20 40% 53
16,671 2000 162 8.1 46 117 12.5% 250
aProportions mapped to Camden population estimates (2011 census). Prevalent and incident dementia cases estimated from CFAS-II data. [25, 47]
Table 3 Key definitions
Delirium: DSM-IV
Duration: Days in delirium, determined by consensus of all data
obtained: direct assessment, informant interview, hospital and
community clinical records.
Severity: Serial Memorial Delirium Assessment Scale (MDAS) scores
associated with each delirium episode.
Aetiology: Principal precipitating causes (infective/inflammatory;
pharmacological; metabolic; other), determined by consensus of all
data obtained.
Cognitive function: Modified Telephone Interview for Cognitive
Status (TICS-m) score.
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Additional data sources
Participants are asked to consent for access to their
NHS medical and social care notes, including data from
GP, community mental health, community rehabilitation
and social services records throughout the duration of
the study. The facility to do this comes from the
Camden Integrated Digital Record.
Statistical methods
Power calculations for hypothesis
Figure 2 shows the expected mortality for hospitalised
persons (delirium and non-delirium). [5, 9, 23, 36] Over-
all mortality in the population aged ≥70 years is 12%/
year (Office for National Statistics). Attrition from
causes other than death is estimated as 10%. Calcula-
tions used the sampsi command in Stata (version 12.1),
and assume α = 0.05 and β = 0.9. The most conservative
estimate of TICS-m standard deviation reported in the
literature (SD = 7.2) was used. [31]
A clinically significant change in the two-year total
TICS-m score would be 6 (out of 50) points for hospita-
lised delirium patients (change within-person for incident
delirium cases) (hypothesis) and 3 points for hospitalised
persons without delirium (compared to delirium cases).
[23, 24] This effect size is consistent with other studies
using this type of primary outcome where incident
delirium was associated with change in global cognition
scales of 2.5 (out of 28) points (Blessed Information-
Memory-Concentration test) [11] and 4 (out of 30) points
(Mini-Mental State Examination). [10]
The resulting sample size is n = 215 to detect the pri-
mary outcome (within-person change in the incident de-
lirium group) and n = 431 to compare differences between
hospitalised participants without delirium. This allows a
margin to assess 70% of admissions or a 50% overestimate
of delirium cases, and still be sufficiently powered.
Statistical analyses
Outcome: TICS-m score at follow-up.
Exposures:
Main exposure: delirium (severity (MDAS scores); dur-
ation (days), modelled as a time-varying covariate across
the whole study period); aetiology (four categories: infect-
ive/inflammatory; metabolic; pharmacological; other).
Confounders: baseline: TICS-m score at baseline, age,
sex, ethnicity (three categories), education level (three
categories); illness severity: APACHE II at admission and
daily total NEWS scores.
Analyses
– Delirium incidence will be expressed as an annual
rate, and described stratified by age.
– Linear regression, where outcome is TICS-m score
at two years, will be used (hypothesis). 14 parame-
ters are proposed, this can be accommodated by a
follow-up sample of 1400.
– Timing of delirium is important and delirium
variables will be analysed as time-varying covariates,
where this can be considered ‘time at risk’ for
change in TICS-m score. This also allows the effects
of recurrent delirium to be assessed and is flexible
for differences in time intervals between delirium
occurrences and follow-up.
– More detailed analyses of trajectories in relation to
repeated TICS-m scores will be possible using
random-effects models. [37]
– Data missing at random will be treated using
multiple imputation.
– Where appropriate, shared parameters models may
jointly link random-effects models with survival
analyses to account for attrition due to death. [38]
Patient and public involvement
Patient and public involvement operates through the for-
mation of a PPI group with input throughout the course
of the study. The group is drawn from interested per-
sons in Camden, including those involved with the CCG,
Age UK, Carers UK, Alzheimer’s Society. The PPI group
is involved in refining the study documentation (PIS,
consent forms), recruitment strategies as well as dissem-
ination of findings. The group meets every four months,
where new study questions and modalities of data
collection are considered.
Discussion
The DELPHIC study represents an opportunity to
characterise prospectively the impact of delirium on
long-term cognitive impairment. It will provide a defini-
tive estimate of cumulative incidence of delirium across
settings in a whole population. Prospectively linking a
community sample with hospitalisations will lead to new
knowledge on pathways to long-term cognitive impair-
ment, overcoming the limitations of previous studies in
selected samples. DELPHIC also offers an opportunity to
explore mechanisms by providing a population frame-
work to nest representative samples testing hypotheses
from experimental studies. [39, 40]
With respect to other cohort studies, DELPHIC is
closely related to CFAS-DECIDE, where the delirium as-
certainment protocols were developed in conjunction.
[41] The community assessments have overlap with
measures undertaken in the MRC National Survey for
Health and Development. [42, 43] In ascertaining both
delirium and dementia, DELPHIC will be a contributing
cohort to the Dementias Platform UK.
Davis et al. BMC Geriatrics  (2018) 18:45 Page 7 of 9
DELPHIC will lead to a resource for insights into the
delirium-dementia relationship from its biological un-
derpinnings through to the public health implications. A
systematic characterisation of temporal patterns of acute
illness, hospitalisation, delirium and cognitive outcomes
is urgently required. [44] DELPHIC will also inform how
underlying dementia influences the incidence and detec-
tion of delirium, by adding empirical data to the clinical
uncertainties surrounding delirium superimposed on
dementia. [45, 46] By analysing whole population
transitions of cognitive function in older people across
healthcare settings, DELPHIC will lead to greater
understanding of progression of cognitive impairments
in ageing.
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